Trial Profile
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of DER 45 EV Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2018
Price :
$35
*
At a glance
- Drugs Benzoyl peroxide (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Acronyms SGTDER45EV
- Sponsors Sol-Gel Technologies
- 26 Mar 2018 According to a Sol-Gel Technologies media release, data from this trial was presented at the American Academy of Dermatology (AAD) Annual Meeting 2018.
- 15 Feb 2018 Primary endpoint has been met. (Change in Inflammatory Lesion Counts From Baseline), as reported in a Sol-Gel Technologies media release.
- 15 Feb 2018 Primary endpoint has been met. (Investigator Global Assessment (IGA) Improvement From Baseline), as reported in a Sol-Gel Technologies media release.